78A-98792-49442

3 vaccinations 11 coded responses 40 check-ins 11 free-text entries 2 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 958 / CA
Registered: 2021-03-11

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-11
Registered in v-safe
2021-03-11
Dose 1 — Moderna
2021-03-11
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-18
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-25
Survey response — day 14, dose 1
MedDRA: Immunisation reaction, Injection site erythema, Injection site mass, Injection site pruritus, Injection site swelling, Injection site warmth — Feeling: Fair

Free text: COVID ARM: Very large swollen hot, itchy, red lump at the injection site. Approximately 3 inches in diameter. Appeared 7 -8 days after first injection and lasted approximately 5 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-01
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-08
Dose 2 — Moderna
2021-04-08
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-04-15
Health check-in — day 7, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-29
Survey response — day 21, dose 2
MedDRA: Fatigue, Headache, Nausea, Pain — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Headaches, fatigue, nausea, body aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Survey response — day 28, dose 2
MedDRA: Abdominal pain, Migraine, Nausea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Extreme abdominal pain, migraines, and nausea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-13
Survey response — day 35, dose 2
MedDRA: Migraine, Nausea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Migraines and nausea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Survey response — day 42, dose 2
MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Migraines

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-08
Survey response — 3 months, dose 2
MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Migraines

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-07
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-11-15
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2021-11-16
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-17
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-18
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-19
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-21
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-11-22
Health check-in — day 7, dose 3
Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-01
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-12-06
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2021-12-13
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-24
Survey response — day 35, dose 3
MedDRA: Cough, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sore throat, cough, congestion, headache

MedDRA releases: 2024-11 · check-in free text available
2021-12-27
Survey response — day 42, dose 3
MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Extremely sore throat, cough, congestion

MedDRA releases: 2024-11 · check-in free text available
2022-02-14
Survey response — 3 months, dose 3
MedDRA: Migraine, Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sore throat, migraines, runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-05-16
Survey response — 6 months, dose 3
MedDRA: Hyperemesis gravidarum — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Hyperemesis gravidarum

MedDRA releases: 2024-11 · check-in free text available
2022-05-16
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-05-17
Call 1 — Left Voicemail
2022-11-15
Survey response — 12 months, dose 3
MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Constant colds

MedDRA releases: 2024-11 · check-in free text available
2022-11-15
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-16
Call 2 — Left Voicemail
2022-11-16
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-11	Moderna
2	2021-04-08	Moderna
3	2021-11-15	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-05-16	Unsuccessful
2022-11-15	Unsuccessful

Free text

Release 6 — day 14, dose 1

2021-03-25

Symptoms: COVID ARM: Very large swollen hot, itchy, red lump at the injection site. Approximately 3 inches in diameter. Appeared 7 -8 days after first injection and lasted approximately 5 days.

Release 8 — day 21, dose 2

2021-04-29

Symptoms: Headaches, fatigue, nausea, body aches

Release 8 — day 28, dose 2

2021-05-06

Symptoms: Extreme abdominal pain, migraines, and nausea

Release 8 — day 35, dose 2

2021-05-13

Symptoms: Migraines and nausea

Release 8 — day 42, dose 2

2021-05-20

Symptoms: Migraines

Release 9 — 3 months, dose 2

2021-07-08

Symptoms: Migraines

Release 10 — day 35, dose 3

2021-12-24

Symptoms: Sore throat, cough, congestion, headache

Release 10 — day 42, dose 3

2021-12-27

Symptoms: Extremely sore throat, cough, congestion

Release 11 — 3 months, dose 3

2022-02-14

Symptoms: Sore throat, migraines, runny nose

Release 11 — 6 months, dose 3

2022-05-16

Symptoms: Hyperemesis gravidarum

Release 12 — 12 months, dose 3

2022-11-15

Symptoms: Constant colds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	✓	✓	✓
SD	Cough	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hyperemesis gravidarum	·	·	✓
SD	Immunisation reaction	✓	✓	✓
SD	Injection site erythema	✓	✓	✓
SD	Injection site mass	✓	✓	✓
SD	Injection site pruritus	✓	✓	✓
SD	Injection site swelling	✓	✓	✓
SD	Injection site warmth	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Nasopharyngitis	·	·	✓
SD	Nausea	✓	✓	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	✓	✓	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release